Retinal Function is Improved in a Murine Model of a Lysosomal Storage Disease Following Bone Marrow Transplantation

2000 ◽  
Vol 71 (5) ◽  
pp. 469-481 ◽  
Author(s):  
Kevin K. Ohlemiller ◽  
Carole A. Vogler ◽  
Marie Roberts ◽  
Nancy Galvin ◽  
Mark S. Sands
2008 ◽  
Vol 47 (06) ◽  
pp. 239-247 ◽  
Author(s):  
S. Kohlfürst ◽  
H. J. Gallowitsch ◽  
E. Kresnik ◽  
P. Lind ◽  
A. B. Mehta ◽  
...  

SummaryGaucher disease is the most prevalent inherited, lysosomal storage disease and is caused by deficient activity of the enzyme β-glucocerebrosidase. Bone and bone marrow alterations are frequent in the most prevalent non-neuronopathic form of Gaucher disease. Imaging of bone manifestations in Gaucher disease is performed by a variety of imaging methods, conventional X-ray and MRI as the most frequently and most important ones. However, different modalities of scintigraphic imaging have also been used. This article gives an overview on scintigraphic imaging with respect to bone manifestations in Gaucher disease discussing the advantages and limitations of scintigraphic imaging in comparison to other imaging methods.


Hepatology ◽  
2000 ◽  
Vol 32 (1) ◽  
pp. 73-81 ◽  
Author(s):  
Antonio Fontanellas ◽  
Frèdèric Mazurier ◽  
Marc Landry ◽  
Laurence Taine ◽  
Carine Morel ◽  
...  

2008 ◽  
Vol 152 (2) ◽  
pp. 286-288 ◽  
Author(s):  
Germaine Pierre ◽  
Geothy Chakupurakal ◽  
Patrick Mckiernan ◽  
Chris Hendriksz ◽  
Sarah Lawson ◽  
...  

Blood ◽  
2001 ◽  
Vol 97 (1) ◽  
pp. 327-329 ◽  
Author(s):  
Mylvaganam Jeyakumar ◽  
Francine Norflus ◽  
Cynthia J. Tifft ◽  
Mario Cortina-Borja ◽  
Terry D. Butters ◽  
...  

Abstract Sandhoff disease is a lysosomal storage disorder characterized by GM2 ganglioside accumulation in the central nervous system (CNS) and periphery. It results from mutations in the HEXB gene, causing a deficiency in β-hexosaminidase. Bone marrow transplantation (BMT), which augments enzyme levels, and substrate deprivation (using the glycosphingolipid biosynthesis inhibitor N-butyldeoxynojirimycin [NB-DNJ]) independently have been shown to extend life expectancy in a mouse model of Sandhoff disease. The efficacy of combining these 2 therapies was evaluated. Sandhoff disease mice treated with BMT and NB-DNJ survived significantly longer than those treated with BMT or NB-DNJ alone. When the mice were subdivided into 2 groups on the basis of their donor bone marrow–derived CNS enzyme levels, the high enzyme group exhibited a greater degree of synergy (25%) than the group as a whole (13%). Combination therapy may therefore be the strategy of choice for treating the infantile onset disease variants.


Sign in / Sign up

Export Citation Format

Share Document